UNSPSC 51172442: Bismuth subcarbonate/morphine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class GA208. This VA Drug Class (GA208) classifies this compound as belonging to the group ANTIDIARRHEAL AGENTS.

UNSPSC 51172442 Bismuth subcarbonate/morphine is a Commodity code that appears in state and local procurement with minimal recent activity directly aligned to its nominal scope. The three recent opportunities tagged under this code—offender drug testing services, a pharmaceutical direct-to-manufacturer contracting RFI, and a multistate cooperative generic pharmaceutical and OTC products RFP—address pharmaceutical procurement and testing services broadly rather than the specific bismuth subcarbonate/morphine product line itself. State and local issuing bodies, when they solicit under this code, are primarily correction and criminal justice departments, health and human services agencies, and cooperative purchasing alliances supporting multi-jurisdictional government procurement.

Recent activity spans Texas (Collin County Community Supervision and Corrections Department, Texas Health and Human Services Commission) and Minnesota-led multistate purchasing (MMCAP, administered by the Minnesota Department of Administration). The Collin County RFP 2026-327 for Offender Specimen Collection and Drug Testing Services, due July 23, 2026, budgets $600,000 over a two-year initial term with optional renewals through 2031 and requires lab certification from SAMHSA, Texas DPS, or CAP; the Texas HHS RFI HHS0017013 (April 3, 2026) seeks vendor capabilities for direct-to-manufacturer pharmacy benefit contracting without binding award values or timelines. The MMCAP RFP S1070000015802, due March 26, 2026, establishes multiple contracts for generic pharmaceuticals and OTC products across participating states including Oregon, with product availability required by May 15, 2026 and contract effectiveness July 1, 2026. The code shows limited procurement momentum and does not align consistently with the specific product nominally described; opportunities under this code warrant verification against actual scope before pursuing.